Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis

Afrifa, 2019, Circulating mitochondria DNA, a non-invasive cancer diagnostic biomarker candidate, Mitochondrion, 47, 238, 10.1016/j.mito.2018.12.003 Akahane, 2007, The role of p53 mutation in the carcinomas arising from endometriosis, Int. J. Gynecol. Pathol., 26, 345, 10.1097/pgp.0b013e31802b41a8 Anastasiu, 2020, Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives, Int. J. Mol. Sci., 21, 10.3390/ijms21051750 Andres, 2018, Polymorphisms of mitochondrial DNA control region are associated to endometriosis, J. Assist. Reprod. Genet., 35, 533, 10.1007/s10815-017-1082-4 Anglesio, 2017, Cancer-Associated Mutations in Endometriosis without Cancer, N. Engl. J. Med., 376, 1835, 10.1056/NEJMoa1614814 Banys-Paluchowski, 2020, Liquid Biopsy in Breast Cancer, Geburtshilfe Frauenheilkd, 80, 1093, 10.1055/a-1124-7225 Barnhart, 2002, Effect of endometriosis on in vitro fertilization, Fertil. Steril., 77, 1148, 10.1016/S0015-0282(02)03112-6 Batzer, 2002, Alu repeats and human genomic diversity, Nat. Rev. Genet., 3, 370, 10.1038/nrg798 Boguszewska-Byczkiewicz, 2020, A comparison of four commercial kits used for isolating circulating cell-free DNA: QuickGeneMINI8L (Kurabo), Maxwell RSC cfDNA Plasma Kit (Promega), cfKapture 21 Kit (MagBio), and QIAamp MinElute ccfDNA Kit (Qiagen), Medical Research Journal, 5, 92, 10.5603/MRJ.a2020.0021 Breitbach, 2014, Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise, J. Appl. Physiol. (1985), 117, 119, 10.1152/japplphysiol.00002.2014 Breitbach, 2014, Direct quantification of cell-free, circulating DNA from unpurified plasma, PLoS One, 9, e87838, 10.1371/journal.pone.0087838 Bulletti, 2010, Endometriosis and infertility, J. Assist. Reprod. Genet., 27, 441, 10.1007/s10815-010-9436-1 Bulun, 2009, Endometriosis, N. Engl. J. Med., 360, 268, 10.1056/NEJMra0804690 Burghaus, 2016, The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and Patients, Geburtshilfe Frauenheilkd, 76, 875, 10.1055/s-0042-106895 Burghaus, 2019, Standards Used by a Clinical and Scientific Endometriosis Center for the Diagnosis and Therapy of Patients with Endometriosis, Geburtshilfe Frauenheilkd, 79, 487, 10.1055/a-0813-4411 Cho, 2012, Mitochondria DNA polymorphisms are associated with susceptibility to endometriosis, DNA Cell Biol., 31, 317, 10.1089/dna.2011.1279 Creed, 2019, Mitochondrial DNA deletions accurately detect endometriosis in symptomatic females of child-bearing age, Biomark Med., 13, 291, 10.2217/bmm-2018-0419 Creed, 2020, How can mitochondrial DNA deletions act as a biomarker for the detection of endometriosis within the clinic?, Biomark Med., 14, 5, 10.2217/bmm-2019-0435 Dawson, 2013, Analysis of circulating tumor DNA to monitor metastatic breast cancer, N. Engl. J. Med., 368, 1199, 10.1056/NEJMoa1213261 de Ziegler, 2010, Endometriosis and infertility: pathophysiology and management, Lancet, 376, 730, 10.1016/S0140-6736(10)60490-4 Diefenbach, 2018, Evaluation of commercial kits for purification of circulating free DNA, Cancer Genet., 228-229, 21, 10.1016/j.cancergen.2018.08.005 Fawzy, 2016, Quantitative analysis of plasma cell-free DNA and its DNA integrity in patients with metastatic prostate cancer using ALU sequence, J. Egypt Natl. Canc. Inst., 28, 235, 10.1016/j.jnci.2016.08.003 Govatati, 2014, Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study, Hum. Reprod., 29, 324, 10.1093/humrep/det387 Govatati, 2012, Mitochondrial genome variations in advanced stage endometriosis: a study in South Indian population, PLoS One, 7, e40668, 10.1371/journal.pone.0040668 Hudson, 2020, Challenges in uncovering non-invasive biomarkers of endometriosis, Exp. Biol. Med. (Maywood), 245, 437, 10.1177/1535370220903270 Hussein, 2019, Plasma ALU-247, ALU-115, and cfDNA Integrity as Diagnostic and Prognostic Biomarkers for Breast Cancer, Appl. Biochem. Biotechnol., 187, 1028, 10.1007/s12010-018-2858-4 Johansson, 2019, Considerations and quality controls when analyzing cell-free tumor DNA, Biomol. Detect. Quantif., 17 Kamel, 2016, Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer, Tumour Biol., 37, 7565, 10.1007/s13277-015-4624-3 Kang, 2016, Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes, Clin. Biochem., 49, 1354, 10.1016/j.clinbiochem.2016.03.012 Kao, 2005, Oxidative damage and mitochondrial DNA mutations with endometriosis, Ann. N. Y. Acad. Sci., 1042, 186, 10.1196/annals.1338.021 Kobayashi, 2014, Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis (review), Mol. Med. Rep., 9, 1483, 10.3892/mmr.2014.2057 Kohler, 2009, Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors, Mol. Cancer, 8, 105, 10.1186/1476-4598-8-105 Kumari, 2019, Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma, Pathol. Oncol. Res., 25, 925, 10.1007/s12253-017-0380-6 Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062 Lou, 2015, A novel Alu-based real-time PCR method for the quantitative detection of plasma circulating cell-free DNA: sensitivity and specificity for the diagnosis of myocardial infarction, Int. J. Mol. Med., 35, 72, 10.3892/ijmm.2014.1991 Lu, 2016, Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients, Clin. Chim. Acta, 452, 109, 10.1016/j.cca.2015.11.009 Lux, 2021, Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients, Geburtshilfe Frauenheilkd, 81, 469, 10.1055/a-1397-7170 Madhavan, 2014, Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis, Breast Cancer Res. Treat, 146, 163, 10.1007/s10549-014-2946-2 Malik, 2011, Mitochondrial DNA as a non-invasive biomarker: accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution bias, Biochem. Biophys. Res. Commun., 412, 1, 10.1016/j.bbrc.2011.06.067 Mauger, 2020, Comparison of commercially available whole-genome sequencing kits for variant detection in circulating cell-free DNA, Sci. Rep., 10, 6190, 10.1038/s41598-020-63102-8 Pavone, 2015, Endometriosis and ovarian cancer: links, risks, and challenges faced, Int. J. Womens Health, 7, 663, 10.2147/IJWH.S66824 Pearce, 2012, Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies, Lancet Oncol., 13, 385, 10.1016/S1470-2045(11)70404-1 Schwarzenbach, 2011, Cell-free nucleic acids as biomarkers in cancer patients, Nat. Rev. Cancer, 11, 426, 10.1038/nrc3066 Strehl, 2014, Correlation of histological and macroscopic findings in peritoneal endometriosis, Int. J. Clin. Exp. Pathol., 7, 152 Streubel, 2019, Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing, Oncotarget, 10, 5690, 10.18632/oncotarget.27183 Stroun, 2001, Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: evidence for a preferential release from viable cells?, Ann. N. Y. Acad. Sci., 945, 258, 10.1111/j.1749-6632.2001.tb03894.x Suda, 2018, Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium, Cell Rep., 24, 1777, 10.1016/j.celrep.2018.07.037 Umetani, 2006, Prediction of breast tumor progression by integrity of free circulating DNA in serum, J. Clin. Oncol., 24, 4270, 10.1200/JCO.2006.05.9493 Umetani, 2006, Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats, Clin. Chem., 52, 1062, 10.1373/clinchem.2006.068577 Vlassov, 2010, Circulating nucleic acids as a potential source for cancer biomarkers, Curr. Mol. Med., 10, 142, 10.2174/156652410790963295 Yamamoto, 2011, PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma, J. Pathol., 225, 189, 10.1002/path.2940 Zachariah, 2009, Circulating cell-free DNA as a potential biomarker for minimal and mild endometriosis, Reprod. Biomed. Online, 18, 407, 10.1016/S1472-6483(10)60100-9 Zachariah, 2008, Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors, Obstet. Gynecol., 112, 843, 10.1097/AOG.0b013e3181867bc0